We have found 414 documents matching your search criteria

  1. Science, research and development - Rousselot global solutions

    Science, research & development Rigorous science: the key to optimization, innovation and reliability In our aim to help you innovate and succeed in your market, we are constantly improving the performance of our ingredients. We seek to diversify our range of end products, reach new markets and unlo

  2. Removing 2.5 tons of waste from the Sorgue river

    As part of World Day of the First Aid, a group of 140 volunteers joined together to remove five tons of waste from the river which crosses through the community. This waste will be treated and recycled. “IT IS NECESSARY TO PRESERVE THE SORGUE” “We are lucky to have a plant located in an exceptional

  3. 404 page not found

    Oops, page not found It's a 404. Don't worry! There is always a way out, let's take you back home Or you can also take a break and watch some videos first

  4. Rousselot® set to inspire at Vitafoods 2022

    Visitors to Rousselot’s booth can also make use of the Live Chat Corner, allowing them to connect and discuss with formulation experts and also explore tailored technical solutions for their specific formulation challenges. Presenting a new perspective on senior joint care In less than 30 years, the

  5. From sludge to fertilizer: recycling gelatin's waste stream at Isle sur la Sorgue

    When gelatin is extracted from bones, sludge is generated in so-called waste streams. However, these streams don’t need to be wasted; instead, they can be upcycled for sustainability. In this article, we will explore how the sludge from gelatin’s water treatment process has been used as an agricultu

  6. Rousselot® Biomedical announces the world's first GMP grade GelMA

    The production of X-Pure GelMA under GMP conditions is a major step forward for companies that require GelMA for clinical use and in body medical applications. Up until now, research grade GelMA was the only available option. The GMP process ensures that Rousselot X-pure GelMAs are consistently prod

  7. Rousselot® obtains patent for StabiCaps™ gelatin for soft gels

    Due to its natural properties, functional benefits and suitability for immediate release dosing, gelatin is the most common gel forming agent used in soft gel production (2) . Launched in 2018, StabiCaps features gelatins that offer superior shell stability and Active Pharmaceutical Ingredient (API)

  8. Students explore sustainability at Rousselot-sponsored farm in Brazil

    Merging agriculture and education in Sitio Duas Cachoeiras Sitio Duas Cachoeiras is located in a rural area in southeast Brazil’s Mantiqueira mountain range, with parts spreading into the states of São Paulo, Minas Gerais, and Rio de Janeiro. The farm merges ecological agriculture with education in

  9. Rousselot® Biomedical announces the launch of Quali-PureTM HGP 2000

    Quali-Pure HGP 2000 for vaccines and wound healing Gelatin, in its non-gelling hydrolyzed form, has long been used as a protein or peptide excipient in vaccine formulations due to its natural biocompatibility and biodegradability and its ability to stabilize vaccines. When used in wound healing, gel

  10. Two health innovations we launched in 2021

    In 2021, we launched two innovations: X-Pure®, GelDAT® Launched in May ‘21 A highly purified gelatin from the X-Pure range , GelDAT® is ideal for research and preclinical development in regenerative medicine, drug release, cell culture, and complex wound dressings. Quali-Pure® Launched in October ‘2